AU4330097A - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- AU4330097A AU4330097A AU43300/97A AU4330097A AU4330097A AU 4330097 A AU4330097 A AU 4330097A AU 43300/97 A AU43300/97 A AU 43300/97A AU 4330097 A AU4330097 A AU 4330097A AU 4330097 A AU4330097 A AU 4330097A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1996/013855 WO1997007798A1 (en) | 1995-08-30 | 1996-08-30 | Pharmaceutical compounds |
| WO613855 | 1996-08-30 | ||
| US3898997P | 1997-02-26 | 1997-02-26 | |
| US60038989 | 1997-02-26 | ||
| US3952997P | 1997-03-03 | 1997-03-03 | |
| US60039529 | 1997-03-03 | ||
| PCT/US1997/015245 WO1998008506A1 (en) | 1996-08-30 | 1997-08-29 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4330097A true AU4330097A (en) | 1998-03-19 |
Family
ID=27365489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU43300/97A Abandoned AU4330097A (en) | 1996-08-30 | 1997-08-29 | Pharmaceutical compounds |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0957912A1 (enrdf_load_stackoverflow) |
| JP (1) | JP2001502297A (enrdf_load_stackoverflow) |
| AU (1) | AU4330097A (enrdf_load_stackoverflow) |
| CA (1) | CA2263420A1 (enrdf_load_stackoverflow) |
| WO (1) | WO1998008506A1 (enrdf_load_stackoverflow) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69626544T2 (de) * | 1995-12-22 | 2004-01-15 | Lilly Co Eli | Arzneistoffe |
| CA2264294A1 (en) * | 1996-08-30 | 1998-03-05 | University Of Hawai'i | Process for preparing pharmaceutical compounds |
| AU4182197A (en) * | 1996-09-06 | 1998-03-26 | Eli Lilly And Company | Process to prepare pharmaceutical compounds |
| JP2001506970A (ja) * | 1996-09-06 | 2001-05-29 | イーライ・リリー・アンド・カンパニー | 方法及び新規な中間体 |
| BR9811252A (pt) * | 1997-02-26 | 2000-09-26 | Lilly Co Eli | Processo para preparação de compostos farmacêuticos |
| WO1998038178A1 (en) * | 1997-02-26 | 1998-09-03 | Eli Lilly And Company | Tripeptide and tetrapeptide pharmaceutical compounds |
| US6180679B1 (en) * | 1998-04-07 | 2001-01-30 | Eli Lilly And Company | Method for treating fungal infections |
| US6376230B1 (en) | 1998-10-16 | 2002-04-23 | Eli Lilly And Company | Stereoselective process for producing intermediates of cryptophycins |
| US6103913A (en) * | 1998-10-16 | 2000-08-15 | Eli Lilly And Company | Process for preparing enollactone derivatives |
| US7303749B1 (en) | 1999-10-01 | 2007-12-04 | Immunogen Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| HK1049787B (en) | 1999-10-01 | 2014-07-25 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| CN1764634A (zh) * | 2003-01-22 | 2006-04-26 | 沃尼尔·朗伯有限责任公司 | 环丙基β-氨基酸衍生物 |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69427706T2 (de) * | 1993-12-21 | 2001-10-25 | University Of Hawaii, Honolulu | Cryptophycine |
| JP2000507805A (ja) * | 1995-08-30 | 2000-06-27 | ユニバーシティ オブ ハワイ | 変形生合成からのクリプトフィシン |
| WO1997031632A1 (en) * | 1996-02-27 | 1997-09-04 | Eli Lilly And Company | Pharmaceutical compounds |
-
1997
- 1997-08-29 JP JP10511080A patent/JP2001502297A/ja active Pending
- 1997-08-29 AU AU43300/97A patent/AU4330097A/en not_active Abandoned
- 1997-08-29 EP EP97941379A patent/EP0957912A1/en not_active Withdrawn
- 1997-08-29 CA CA002263420A patent/CA2263420A1/en not_active Abandoned
- 1997-08-29 WO PCT/US1997/015245 patent/WO1998008506A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001502297A (ja) | 2001-02-20 |
| WO1998008506A1 (en) | 1998-03-05 |
| EP0957912A4 (enrdf_load_stackoverflow) | 1999-12-22 |
| EP0957912A1 (en) | 1999-11-24 |
| CA2263420A1 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9602080D0 (en) | Pharmaceutical compounds | |
| AU4762797A (en) | Pharmaceutical compositions | |
| AU2967597A (en) | Pharmaceutical compositions | |
| AU6740298A (en) | Pharmaceutical composition | |
| AU2533495A (en) | Pharmaceutical diketopiperazine compounds | |
| AU2186797A (en) | Pharmaceutically useful compounds | |
| AU6904896A (en) | Pharmaceutical compounds | |
| AU3777897A (en) | Pharmaceutical compositions | |
| AU4925697A (en) | Compounds | |
| AU8591898A (en) | Pharmaceutical compounds | |
| AU4326197A (en) | Pharmaceutical compositions | |
| GB9609976D0 (en) | Pharmaceutical compounds | |
| AU4330097A (en) | Pharmaceutical compounds | |
| GB9621789D0 (en) | Pharmaceutical compounds | |
| AU2531295A (en) | Pharmaceutical composition | |
| AU9343098A (en) | Pharmaceutical composition | |
| AU4169897A (en) | Pharmaceutical compounds | |
| ZA979329B (en) | Pharmaceutical compounds | |
| AU6480299A (en) | Pharmaceutical compounds | |
| AU7546096A (en) | Pharmaceutical compounds | |
| GB9626151D0 (en) | Pharmaceutical compounds | |
| AUPN862596A0 (en) | Pharmaceutical compositions | |
| AU4457597A (en) | Pharmaceutical compositions | |
| AU5184599A (en) | Pharmaceutical compounds | |
| AU5330198A (en) | Therapeutic compounds |